Functional Evaluation of Lipid-Lowering Therapy by Pravastatin Response

Circulation - United States
doi 10.1161/01.cir.97.18.1874
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Lipid Lowering Therapy and Circulating PCSK9 Concentration

Journal of Atherosclerosis and Thrombosis
BiochemistryInternal MedicineCardiovascular MedicineCardiology
2017English

Evaluation of the Effectiveness of Lipid-Lowering Agents

The Scientific Notes of the Pavlov University
2020English

Controversial Issues of Pathogenesis and Lipid-Lowering Therapy of Atherosclerosis

Clinical pharmacology and therapy
2019English

Three-Year Dynamics and Unsolved Problems of Lipid-Lowering Therapy

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2015English

Regression of Atherosclerotic Renal Artery Stenosis With Aggressive Lipid Lowering Therapy

Journal of Human Hypertension
Internal Medicine
2001English

The Role of Aggressive Lipid Lowering Therapy for Coronary Artery Disease

Juntendo Medical Journal
2019English

Quality of Lipid-Lowering Therapy in Outpatient Practice: RECVAS Register Data

Profilakticheskaya Meditsina
Health PolicyPublic HealthOccupational HealthEnvironmental
2016English

Pravastatin Therapy Fails to Suppress Post-Pci Inflammatory Response Measured by Serum Neopterin and CRP Levels

Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology
2011English

Intensive Lipid Lowering by Statin Therapy Does Not Improve Vasoreactivity in Patients With Type 2 Diabetes

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy